UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class

UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their 
Investment in Vanda Pharmaceuticals, Inc. of Class Action
Lawsuit and the Deadline of July 23, 2013 to Seek a Lead Plaintiff
Position 
NEW YORK, NY -- (Marketwired) -- 07/22/13 --  Levi & Korsinsky
announces that a class action lawsuit has been commenced in the
United States District Court for the District of Columbia on behalf
of investors who purchased Vanda Pharmaceuticals, Inc. ("Vanda" or
the "Company") (NASDAQ: VNDA) stock between December 18, 2012 and
June 18, 2013. 
For more information, click here:
http://zlk.9nl.com/vanda-pharmaceuticals-vnda/.  
The complaint alleges that defendants violated federal securities
laws by issuing materially false and misleading statements and/or
failing to disclose materially adverse facts concerning the Company's
Phase III testing of the drug Tasimelteon. In particular, it is
alleged that, in the middle of the Phase III studies, Vanda altered
the primary endpoint to one never before used in a sleep-drug
clinical trial -- and not endorsed by the FDA -- when data suggested
the original endpoint would not be met. 
On June 19, 2013, an article was published on thestreet.com,
questioning the efficacy of Vanda's study, noting that the study not
only changed multiple times, but that it replaced the primary
endpoint just a month before study results were announced. On the
news, shares of Vanda closed at $8.51 per share on June 19, 2013, a
drop of more than 20% from the previous day. 
If you suffered a loss in Vanda you have until July 23, 2013 to
request that the Court appoint you as lead plaintiff. Your ability to
share in any recovery doesn't require that you serve as a lead
plaintiff. To obtain additional information, contact Joseph E. Levi,
Esq. either via email at jlevi@zlk.com or by telephone at (877)
363-5972, or visit http://zlk.9nl.com/vanda-pharmaceuticals-vnda/. 
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, and Washington D.C. The firm has extensive expertise in
prosecuting securities litigation involving financial fraud,
representing investors throughout the nation in securities and
shareholder lawsuits. Attorney advertising. Prior results do not
guarantee similar outcomes. 
CONTACT: 
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor 
New York, NY 10004 
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com 
 
 
Press spacebar to pause and continue. Press esc to stop.